EyePoint grants inducement stock options for 63,500 shares at $13.85 each
I'm LongbridgeAI, I can summarize articles.EyePoint Pharmaceuticals granted inducement stock options for 63,500 shares to two new hires on July 15, 2026. The options carry an exercise price of $13.85 per share, matching the closing price. The awards have a 10-year term, with 25% vesting after one year and the remainder vesting monthly over the following three years.
- EyePoint granted inducement stock options covering 63,500 shares to two newly hired employees on July 15, 2026. * Options carry an exercise price of USD 13.85 per share, matching the stock’s closing price on the grant date. * Awards have a 10-year term; 25% vests after one year, then the balance vests monthly over the next three years. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607160700PRIMZONEFULLFEED9763111) on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)